Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
FEBS Letters|July 9, 2025
Cyclic nucleotide signaling as a drug target in retinitis pigmentosaKatri Vainionpää, Ahmed B Montaser, Henri Leinonen
Redox Biology|January 29, 2026
Female sex is a risk factor for exacerbated lipid peroxidation and disease in murine retinitis pigmentosaKatri Vainionpää, Anna Kalatanova, Umair Seemab, et al.
Molecules (Basel, Switzerland)|January 11, 2022
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by LigandsJohanna Huttunen, Mahmoud Agami, Janne Tampio, et al.
Pharmaceutical Research|March 8, 2022
Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug DeliveryKristiina M Huttunen, Tetsuya Terasaki, Arto Urtti, et al.
Chemico-Biological Interactions|December 15, 2023
Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific mannerJohanna Huttunen, Janne Tampio, Juulia Järvinen, et al.
Molecular Pharmaceutics|January 23, 2023
Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing ProdrugsJohanna Huttunen, Thales Kronenberger, Ahmed B Montaser, et al.
European Journal of Pharmacology|February 22, 2025
A novel paracetamol derivative alleviates lipopolysaccharide-induced neuroinflammationAdéla Králová, Ahmed B Montaser, Janne Tampio, et al.
Frontiers in Pharmacology|November 7, 2022
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brainAgathe Hugele, Susanne Löffler, Belén Hernández Molina, et al.
ACS Chemical Neuroscience|November 24, 2020
L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal CellsAhmed B Montaser, Juulia Järvinen, Susanne Löffler, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 5, 2024
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statinsLuna Prieto Garcia, Anna Vildhede, Pär Nordell, et al.
Pageof 2